Clinical Trials Logo

Clinical Trial Summary

Periprosthetic bone loss caused by stress-shielding effect, a phenomenon of bone atrophy under mechanical unloading after THR implantation, further compromises the longevity of implant. The prospective randomized study is aimed to investigate the periprosthetic bone loss after primary total hip replacements.


Clinical Trial Description

This study is a prospective, randomized, open-label clinical trial. The study will be performed in patients after obtaining informed consent. Group assignment is by drawing a sealed envelops based on random table. (1) Group 1: Experimental group 30 cases, Aclasta® (Zoledronic acid 5mg/100ml) is given intravenously on the 4th postoperative day and one year after the total hip replacement, (2) Group 2: Control group, 30 cases, no bisphosphonate is given to the patients. Only the unilateral coxarthrosis will be recruited for the study. Patients will be analyzed with (1) DXA study (2) Clinical assessment (Harris hip score and SF-12) (3) X-ray (4) serum marker of bone turnover. Patients will be scheduled for specified examinations preoperatively, postoperatively 6 weeks, 3 months, 6 months, 12 months, and 24 months. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02838121
Study type Interventional
Source Chang Gung Memorial Hospital
Contact
Status Completed
Phase Phase 3
Start date December 2009
Completion date June 2016

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03308929 - Prospective G7 Dual Mobility Total Hip PMCF
Completed NCT04038918 - The Effectiveness of Progressive Relaxation Exercises N/A
Not yet recruiting NCT06132880 - Effects of Human Urinary Kallidinogenase on Early Improvement and Functional Outcomes in Acute Ischemic Stroke (TK-SPEED) N/A
Completed NCT03188809 - Adductor Canal Block Versus Femoral Nerve Block With Repeated Bolus Doses Arthroplasty N/A